celecoxib has been researched along with d-alpha tocopherol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Elguero, J; Silva, AMS; Silva, VLM | 1 |
| Kline, K; Lawson, KA; Sanders, BG; Simmons-Menchaca, M; Sun, L; Zhang, S | 1 |
| Astara, G; Deiana, L; Gramignano, G; Lusso, MR; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Serpe, R | 1 |
| Jin, H; Koo, PT; Tsang, DJ; Xiao, H; Yang, CS; Yang, Z | 1 |
| Shirode, AB; Sylvester, PW | 1 |
| Brand, RE; Singh, SV; Stan, SD | 1 |
| Mosquera-Giraldo, LI; Taylor, LS; Trasi, NS | 1 |
| Baek, IH; Cho, W; Choo, GH; Ha, ES; Hwang, SJ; Jeong, HY; Jung, YS; Kim, JS; Kim, MS; Noh, J; Ok, J | 1 |
| Catenacci, L; Mandracchia, D; Perteghella, S; Sorrenti, M; Torre, ML; Trapani, A; Trapani, G; Tripodo, G | 1 |
| Izadi, G; Sepehri, G; Shamsi Meymandi, M; Zamiri, Z | 1 |
| Subongkot, T | 1 |
| Carpi, A; Ferrari, P; Morganti, R; Nicolini, A | 1 |
| He, K; Jiang, M; Li, J; Liu, Q; Qiu, T; Sun, J; Yang, M; Zhan, S; Zhang, X | 1 |
3 review(s) available for celecoxib and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current progress on antioxidants incorporating the pyrazole core.
Topics: Animals; Antioxidants; Drug Discovery; Humans; Oxidative Stress; Pyrazoles; Structure-Activity Relationship | 2018 |
Chemoprevention strategies for pancreatic cancer.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Camellia sinensis; Celecoxib; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Disease Models, Animal; Down-Regulation; Drug Synergism; Gemcitabine; Humans; Isothiocyanates; Pancreatic Neoplasms; Phototherapy; Pyrazoles; Sulfonamides; Tea; Vitamin D; Vitamin E | 2010 |
1 trial(s) available for celecoxib and d-alpha tocopherol
| Article | Year |
|---|---|
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
Topics: Adult; Aged; Anorexia; Ascorbic Acid; Cachexia; Carbocysteine; Celecoxib; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Linear Models; Male; Medroxyprogesterone; Middle Aged; Neoplasms; Nutritional Support; Oxidative Stress; Pyrazoles; Statistics, Nonparametric; Sulfonamides; Thioctic Acid; Treatment Outcome; Vitamin A; Vitamin E | 2006 |
11 other study(ies) available for celecoxib and d-alpha tocopherol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Celecoxib; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Pyrazoles; Sulfonamides; Tocopherols; Transplantation, Heterologous; Vitamin E | 2004 |
Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
Topics: Atorvastatin; Celecoxib; Cell Cycle; Cell Division; Cell Line, Tumor; Chromans; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Synergism; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Polyisoprenyl Phosphates; Pyrazoles; Pyrroles; Sulfonamides; Vitamin E | 2010 |
Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Line, Tumor; Chromans; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; NF-kappa B; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; Sulfonamides; Vitamin E | 2010 |
Impact of surfactants on the crystal growth of amorphous celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Stability; Polyethylene Glycols; Polymers; Povidone; Pyrazoles; Sodium Dodecyl Sulfate; Solubility; Sucrose; Sulfonamides; Surface-Active Agents; Temperature; Vitamin E; X-Ray Diffraction | 2014 |
Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Topics: Celecoxib; Excipients; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyethylene Glycols; Pyrazoles; Solubility; Sulfonamides; Surface Properties; Surface-Active Agents; Vitamin E; X-Ray Diffraction | 2015 |
pH-sensitive inulin-based nanomicelles for intestinal site-specific and controlled release of celecoxib.
Topics: Administration, Oral; alpha-Tocopherol; Caco-2 Cells; Celecoxib; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Inulin; Micelles | 2018 |
Evidence for antinociceptive effects of combined administration of vitamin E and celecoxib in tail-flick and formalin test in male rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Formaldehyde; Indomethacin; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Vitamin E | 2019 |
Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib.
Topics: Administration, Oral; Animals; Celecoxib; Cell Death; Drug Liberation; Electric Conductivity; Electric Impedance; Emulsions; Humans; Intestinal Absorption; Intestinal Mucosa; Kinetics; Particle Size; Permeability; Rheology; Solubility; Static Electricity; Surface-Active Agents; Swine; Vitamin E | 2019 |
Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
Topics: Adult; Aged; alpha-Tocopherol; Antineoplastic Agents; Breast Neoplasms; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Dexamethasone; Diterpenes; Female; Humans; Immunosuppressive Agents; Interleukins; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Retinyl Esters; Tumor Burden; Tumor Escape; Vitamin A; Vitamins | 2019 |
Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Celecoxib; Lignans; Mice; Mice, Inbred BALB C; Polyesters; Polyethylene Glycols; Vitamin E | 2020 |